216 related articles for article (PubMed ID: 12890804)
41. [Immunohistochemical and molecular characterization of systemic mastocytoses].
Sotlar K
Verh Dtsch Ges Pathol; 2005; 89():245-53. PubMed ID: 18035698
[TBL] [Abstract][Full Text] [Related]
42. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
43. Splenic mastocytosis: report of two cases and detection of the transforming somatic C-KIT mutation D816V.
Wimazal F; Schwarzmeier J; Sotlar K; Simonitsch I; Sperr WR; Fritsche-Polanz R; Födinger M; Schubert J; Horny HP; Valent P
Leuk Lymphoma; 2004 Apr; 45(4):723-9. PubMed ID: 15160946
[TBL] [Abstract][Full Text] [Related]
44. The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.
De Matteis G; Zanotti R; Colarossi S; De Benedittis C; Garcia-Montero A; Bonifacio M; Sartori M; Aprili F; Caruso B; Paviati E; Carli G; Perbellini O; Zamò A; Bonadonna P; Pizzolo G; Guidi G; Martinelli G; Soverini S
Leuk Res; 2015 Mar; 39(3):273-8. PubMed ID: 25582384
[TBL] [Abstract][Full Text] [Related]
45. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
Siegert SI; Diebold J; Ludolph-Hauser D; Löhrs U
Am J Clin Pathol; 2004 Oct; 122(4):560-5. PubMed ID: 15487454
[TBL] [Abstract][Full Text] [Related]
46. Systemic mastocytosis (SM) and associated malignant bone marrow histiocytosis - a hitherto undescribed form of SM-AHNMD.
Rudzki Z; Sotlar K; Kudela A; Starzak-Gwóźdź J; Horny HP
Pol J Pathol; 2011; 62(2):101-4. PubMed ID: 21866466
[TBL] [Abstract][Full Text] [Related]
47. The faces of mast cell disease: bone marrow infiltrates in 3 patients with systemic mastocytosis.
Martinez AE; Medina AM; Hyde JA; Krill-Jackson E; Blaustein A; Schwartz M; Cabello-Inchausti B
Ann Diagn Pathol; 2005 Apr; 9(2):81-5. PubMed ID: 15806514
[TBL] [Abstract][Full Text] [Related]
48. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma.
Kim Y; Weiss LM; Chen YY; Pullarkat V
Leuk Res; 2007 Dec; 31(12):1749-54. PubMed ID: 17544505
[TBL] [Abstract][Full Text] [Related]
49. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
[TBL] [Abstract][Full Text] [Related]
50. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
[TBL] [Abstract][Full Text] [Related]
51. Role of immunoglobulin heavy and light chain gene rearrangement analysis in differentiating between benign and malignant bone marrow B-cell lymphoid aggregates.
Evans MG; Brynes RK; Crymes A; Reid J; Haghighi N; Botros C; Zhao X; Rezk SA
Hum Pathol; 2022 Dec; 130():58-64. PubMed ID: 36252861
[TBL] [Abstract][Full Text] [Related]
52. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.
Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866
[TBL] [Abstract][Full Text] [Related]
53. Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2012 Apr; 87(4):401-11. PubMed ID: 22410759
[TBL] [Abstract][Full Text] [Related]
54. Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val.
Sperr WR; Walchshofer S; Horny HP; Födinger M; Simonitsch I; Fritsche-Polanz R; Schwarzinger I; Tschachler E; Sillaber C; Hagen W; Geissler K; Chott A; Lechner K; Valent P
Br J Haematol; 1998 Dec; 103(3):740-9. PubMed ID: 9858225
[TBL] [Abstract][Full Text] [Related]
55. Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens.
Horny HP; Wehrmann M; Griesser H; Tiemann M; Bültmann B; Kaiserling E
Am J Clin Pathol; 1993 Feb; 99(2):142-9. PubMed ID: 8438787
[TBL] [Abstract][Full Text] [Related]
56. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases.
Thériault C; Galoin S; Valmary S; Selves J; Lamant L; Roda D; Rigal-Huguet F; Brousset P; Delsol G; Al Saati T
Mod Pathol; 2000 Dec; 13(12):1269-79. PubMed ID: 11144922
[TBL] [Abstract][Full Text] [Related]
57. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.
Pardanani A
Am J Hematol; 2013 Jul; 88(7):612-24. PubMed ID: 23720340
[TBL] [Abstract][Full Text] [Related]
58. Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation.
Zuluaga Toro T; Hsieh FH; Bodo J; Dong HY; Hsi ED
Br J Haematol; 2007 Oct; 139(1):31-40. PubMed ID: 17662084
[TBL] [Abstract][Full Text] [Related]
59. Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow.
Natkunam Y; Rouse RV
Am J Surg Pathol; 2000 Jan; 24(1):81-91. PubMed ID: 10632491
[TBL] [Abstract][Full Text] [Related]
60. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques.
Pittaluga S; Tierens A; Dodoo YL; Delabie J; De Wolf-Peeters C
Am J Clin Pathol; 1999 Feb; 111(2):179-84. PubMed ID: 9930138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
